Use of non‐vitamin K antagonist oral anticoagulants in atrial fibrillation patients: insights from a specialist atrial fibrillation clinic

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. 11, 2015-11 ,pp. : 1341-1348

John Wiley & Sons Inc

Access to resources Recommend Favorite

European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation

By Heidbuchel Hein   Verhamme Peter   Alings Marco   Antz Matthias   Hacke Werner   Oldgren Jonas   Sinnaeve Peter   Camm A. John   Kirchhof Paulus  

EP-Europace, Vol. 15, Iss. 5, 2013-05 ,pp. : 625-651

Oxford University Press

Access to resources Recommend Favorite

Self-Management of Oral Anticoagulants with a Whole Blood Prothrombin-Time Monitor in Elderly Patients with Atrial Fibrillation

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 32, Iss. 3, 2002-10 ,pp. : 99-106

Karger

Access to resources Recommend Favorite

Risk Prediction for Adverse Events during Initiation of Sotalol and Dofetilide for the Treatment of Atrial Fibrillation

By  

PACING AND CLINICAL ELECTROPHYSIOLOGY, Vol. 38, Iss. 4, 2015-04 ,pp. : 490-498

John Wiley & Sons Inc

Access to resources Recommend Favorite

Non‐vitamin K antagonist oral anticoagulants (NOACs) in patients with concomitant atrial fibrillation and heart failure: a systemic review and meta‐analysis of randomized trials

By  

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 17, Iss. 11, 2015-11 ,pp. : 1192-1200

John Wiley & Sons Inc

Access to resources Recommend Favorite